FDA
-
-
-
-
-
-
-
Mizuho on uniQure BV (QURE): 'expressed confidence the overall signal — namely the slowing of disease progression — should remain directionally consistent'
-
-
-
-
-
-
-
FDA Commissioner Marty Makary is resigning - Politico reporter on X
-
-
-
-
-
-
-
Portnoy Law Firm Announces Class Action on Behalf of uniQure N.V. Investors
-
-
-
-
-
-
-
Mizuho Upgrades uniQure BV (QURE) to Outperform, Raise PT to $35
-
-
-
-
-
-
-
uniQure Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against uniQure N.V. - QURE
-
-
-
-
-
-
-
Class Action Filed Against uniQure N.V. (QURE) Seeking Recovery for Investors - Contact The Gross Law Firm
-
-
-
-
-
-
-
uniQure BV (QURE) PT Lowered to $14 at Stifel on FDA uncertainty
-
328,147 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

